The ROE as of December 2024 (TTM) for Coherus BioSciences, Inc. (CHRS) is 0.40%

According to Coherus BioSciences, Inc.’s latest financial reports and current stock price. The company's current ROE is 0.40%. This represents a change of -102.83% compared to the average of -14.23% of the last 4 quarters.

Coherus BioSciences, Inc. (CHRS) Historical ROE (quarterly & annually)

How has CHRS ROE performed in the past?

The mean historical ROE of Coherus BioSciences, Inc. over the last ten years is 237.58%. The current 0.40% ROE has changed -99.83% with respect to the historical average. Over the past ten years (40 quarters), CHRS's ROE was at its highest in in the March 2018 quarter at 2.47%. The ROE was at its lowest in in the March 2022 quarter at -885.48%.

Coherus BioSciences, Inc. (CHRS) ROE by Quarter and Year

Discovering the peaks and valleys of Coherus BioSciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Coherus BioSciences, Inc. (CHRS) Average ROE

How has CHRS ROE performed in the past?

The current ROE of Coherus BioSciences, Inc. (CHRS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Coherus BioSciences, Inc. (CHRS) ROE vs. Peers

How is CHRS’s ROE compared to its peers?

Coherus BioSciences, Inc.’s ROE is greater than Assembly Biosciences, Inc. (-121.46%), less than Spero Therapeutics, Inc. (3.36%), greater than Achilles Therapeutics plc (-54.57%), greater than Instil Bio, Inc. (-37.44%), greater than Neoleukin Therapeutics, Inc. (-8.54%), greater than NextCure, Inc. (-62.50%), greater than Nuvation Bio Inc. (-108.68%), greater than CytomX Therapeutics, Inc. (-41.34%), greater than Bolt Biotherapeutics, Inc. (-69.46%), greater than Gracell Biotechnologies Inc. (-15.56%),

Build a custom stock screener for Coherus BioSciences, Inc. (CHRS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Coherus BioSciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Coherus BioSciences, Inc. (CHRS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Coherus BioSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.